Skip to main navigation Skip to search Skip to main content

Injection frequency, loading dose completion and 12 month outcomes of anti-VEGF treatment in diabetic macular oedema

  • Tunde Peto (Speaker)
  • Xin Chen (Contributor to Paper or Presentation)
  • Faruque D. Ghanchi (Contributor to Paper or Presentation)
  • Geeta Menon (Contributor to Paper or Presentation)
  • James Talks (Contributor to Paper or Presentation)
  • Fulcher, C. (Contributor to Paper or Presentation)
  • Qi Yang (Contributor to Paper or Presentation)
  • Huanxiang Lu (Contributor to Paper or Presentation)
  • Hemanth Machavaram (Contributor to Paper or Presentation)
  • Gloria Chi (Contributor to Paper or Presentation)

Activity: Talk or presentation types › Poster presentation

Description

Assess the association between anti-vascular endothelial growth factor (VEGF) treatment and 12-month functional and anatomic outcomes in diabetic macular oedema (DMO), adjusting for confounders and investigating effect modification by baseline characteristics.
Period28 May 2026 → 30 May 2026
Event title36th Annual Conference of the European Association for Diabetic Eye Complications
Event typeConference
LocationOslo, NorwayShow on map
Degree of RecognitionInternational